Very very positive! Especially for the initial low dose intertumoral which was completed in April. Dose level 2 cannot be too far away. If there are signs of efficacy in the first dose looking forward to seeing disease control at double the dose and the addition of intraventricular administration.
Well done CHM. Webinar too! Good stuff..
- Forums
- ASX - By Stock
- CHM
- Ann: CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA
CHM
chimeric therapeutics limited
Add to My Watchlist
25.0%
!
0.3¢

Ann: CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $9.323M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $22.28K | 6.311M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
78 | 84735861 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 86304338 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
71 | 80251196 | 0.003 |
24 | 24996485 | 0.002 |
12 | 52464000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 86304338 | 23 |
0.005 | 33049651 | 21 |
0.006 | 12474007 | 15 |
0.007 | 6512518 | 7 |
0.008 | 7317101 | 5 |
Last trade - 14.27pm 25/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online